» Articles » PMID: 39822293

Incidence of Dementia in the German Heinz Nixdorf Recall Study over 20 Years

Overview
Date 2025 Jan 17
PMID 39822293
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The aim of the study was to estimate the population-based dementia incidence in Germany over a period of two decades.

Methods: We analyzed data from 4814 participants of the population-based Heinz Nixdorf Recall study (49.8% men, 45-75 years at baseline period 2000-2003), who have been monitored for the occurrence of cognitive decline and dementia. We calculated the cumulative incidence of dementia and its major subtypes and the incidence rate per 1000 person-years over two decades.

Results: During a median follow-up of 18.2 (Q1-Q3: 11.3-20.6) years, a total of 298 participants (6.2%) developed dementia (22.1% Alzheimer´s disease, 23.5% vascular dementia, 15.1% mixed dementia, 9.1% other dementia, 30.2% unspecified). The overall incidence rate was 3.9 per 1000 person-years.

Discussion: Our study is the only current population-based study in Germany that estimates the incidence of dementia. In order to reduce the high proportion of unspecific dementia diagnoses, diagnostics urgently need to be improved.

Highlights: New data on the incidence of dementia in Germany in participants ≥45 years of age.Participants have been monitored for dementia incidence over two decades.The overall incidence in our cohort was 3.9 per 1000 person-years.Many patients had unspecific dementia diagnoses in their medical records.Further diagnostic evaluation should be available for all dementia patients.

Citing Articles

Incidence of dementia in the German Heinz Nixdorf Recall study over 20 years.

Schramm S, Rinck C, Krizanovic N, Jockel K, Husing A, Gronewold J Alzheimers Dement (Amst). 2025; 17(1):e70061.

PMID: 39822293 PMC: 11736620. DOI: 10.1002/dad2.70061.

References
1.
Schramm S, Rinck C, Krizanovic N, Jockel K, Husing A, Gronewold J . Incidence of dementia in the German Heinz Nixdorf Recall study over 20 years. Alzheimers Dement (Amst). 2025; 17(1):e70061. PMC: 11736620. DOI: 10.1002/dad2.70061. View

2.
Muller-Gerards D, Weimar C, Abramowski J, Tebrugge S, Jokisch M, Dragano N . Subjective cognitive decline, ε4, and incident mild cognitive impairment in men and women. Alzheimers Dement (Amst). 2019; 11:221-230. PMC: 6404645. DOI: 10.1016/j.dadm.2019.01.007. View

3.
Wolters F, Chibnik L, Waziry R, Anderson R, Berr C, Beiser A . Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium. Neurology. 2020; 95(5):e519-e531. PMC: 7455342. DOI: 10.1212/WNL.0000000000010022. View

4.
. 2024 Alzheimer's disease facts and figures. Alzheimers Dement. 2024; 20(5):3708-3821. PMC: 11095490. DOI: 10.1002/alz.13809. View

5.
Livingston G, Huntley J, Liu K, Costafreda S, Selbaek G, Alladi S . Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024; 404(10452):572-628. DOI: 10.1016/S0140-6736(24)01296-0. View